Gylden Pharma Email Format

Biotechnology ResearchEngland, United Kingdom11-50 Employees

Gylden Pharma is a clinical-stage, privately held biotechnology company based in Abingdon, Oxfordshire. It conducts its research and GMP manufacturing at facilities in Milton Park, supporting the development of synthetic T cell-priming vaccines and immunotherapies designed to mobilize the body's cellular immune response to pathogen-infected cells. The delivery approach centers on skin-based administration using a patch system to facilitate practical deployment, with in-house manufacturing capabilities sustaining development and production.

Its infectious disease pipeline includes candidates aimed at Betacoronaviruses, dengue fever, and universal influenza, as well as intracellular bacterial infections. The portfolio also encompasses a patch-based therapy for migraines and candidates in cardiometabolic disorders and cancer immunotherapy, reflecting a broader focus within immunotherapy and vaccine development. Gylden operates internationally, maintaining a subsidiary in Doylestown, PA, and a manufacturing facility in Fremont, CA, alongside a UK base, signaling a global development and production footprint.

Get verified Gylden Pharma emails free

Company overview Employee directory